Cargando…

Allergen Management in Children with Type 2-High Asthma

Children exposed to various indoor and outdoor allergens are placed at an increased risk of developing asthma in later life, with sensitization in these individuals being a strong predictor of disease morbidity. In addition, aeroallergen exposure influences asthma outcomes through an interplay with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray-Ffrench, Madeleine, Fernandes, Ricardo M, Sinha, Ian P, Abrams, Elissa M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976481/
https://www.ncbi.nlm.nih.gov/pubmed/35378923
http://dx.doi.org/10.2147/JAA.S276994
_version_ 1784680578975531008
author Gray-Ffrench, Madeleine
Fernandes, Ricardo M
Sinha, Ian P
Abrams, Elissa M
author_facet Gray-Ffrench, Madeleine
Fernandes, Ricardo M
Sinha, Ian P
Abrams, Elissa M
author_sort Gray-Ffrench, Madeleine
collection PubMed
description Children exposed to various indoor and outdoor allergens are placed at an increased risk of developing asthma in later life, with sensitization in these individuals being a strong predictor of disease morbidity. In addition, aeroallergen exposure influences asthma outcomes through an interplay with adverse determinants of health. The goal of this review is to provide an introductory overview of factors related to aeroallergen exposure in type 2-high childhood asthma. These include the relevance of exposure in asthma exacerbations and severity, and the evidence-base for avoidance and treatment for sensitization to these allergens. This review will focus on both indoor aeroallergens (house dust mite, pet, cockroach, mold, and rodent) and outdoor aeroallergens (pollens and molds). Treatment of aeroallergen sensitization in children with asthma includes avoidance and removal measures, although there is limited evidence of clinical benefit especially with single-strategy approaches. We will also address the interplay of aeroallergens and climate change, adverse social determinants, and the current COVID-19 pandemic, when we have seen a dramatic reduction in asthma exacerbations and emergency department visits among children. While there are many factors that are hypothesized to contribute to this reduction, among them is a reduced exposure to outdoor seasonal aeroallergens.
format Online
Article
Text
id pubmed-8976481
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89764812022-04-03 Allergen Management in Children with Type 2-High Asthma Gray-Ffrench, Madeleine Fernandes, Ricardo M Sinha, Ian P Abrams, Elissa M J Asthma Allergy Review Children exposed to various indoor and outdoor allergens are placed at an increased risk of developing asthma in later life, with sensitization in these individuals being a strong predictor of disease morbidity. In addition, aeroallergen exposure influences asthma outcomes through an interplay with adverse determinants of health. The goal of this review is to provide an introductory overview of factors related to aeroallergen exposure in type 2-high childhood asthma. These include the relevance of exposure in asthma exacerbations and severity, and the evidence-base for avoidance and treatment for sensitization to these allergens. This review will focus on both indoor aeroallergens (house dust mite, pet, cockroach, mold, and rodent) and outdoor aeroallergens (pollens and molds). Treatment of aeroallergen sensitization in children with asthma includes avoidance and removal measures, although there is limited evidence of clinical benefit especially with single-strategy approaches. We will also address the interplay of aeroallergens and climate change, adverse social determinants, and the current COVID-19 pandemic, when we have seen a dramatic reduction in asthma exacerbations and emergency department visits among children. While there are many factors that are hypothesized to contribute to this reduction, among them is a reduced exposure to outdoor seasonal aeroallergens. Dove 2022-03-29 /pmc/articles/PMC8976481/ /pubmed/35378923 http://dx.doi.org/10.2147/JAA.S276994 Text en © 2022 Gray-Ffrench et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Gray-Ffrench, Madeleine
Fernandes, Ricardo M
Sinha, Ian P
Abrams, Elissa M
Allergen Management in Children with Type 2-High Asthma
title Allergen Management in Children with Type 2-High Asthma
title_full Allergen Management in Children with Type 2-High Asthma
title_fullStr Allergen Management in Children with Type 2-High Asthma
title_full_unstemmed Allergen Management in Children with Type 2-High Asthma
title_short Allergen Management in Children with Type 2-High Asthma
title_sort allergen management in children with type 2-high asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976481/
https://www.ncbi.nlm.nih.gov/pubmed/35378923
http://dx.doi.org/10.2147/JAA.S276994
work_keys_str_mv AT grayffrenchmadeleine allergenmanagementinchildrenwithtype2highasthma
AT fernandesricardom allergenmanagementinchildrenwithtype2highasthma
AT sinhaianp allergenmanagementinchildrenwithtype2highasthma
AT abramselissam allergenmanagementinchildrenwithtype2highasthma